SRPT vs VCYT · rev $1.13B vs P/E 47, rev $289.4M
Sarepta Therapeutics Inc (SRPT) versus Veracyte Inc (VCYT) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported VCYT revenue for 2026-06-30 was $289.4M. Net income was $54.2M. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.
SRPT currently screens at market cap $2.34B. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.
Not investment advice. Open the SRPT and VCYT stock pages for the full models.
Not investment advice.